You planned to run six miles today, but now all you can think about is how the hell you’re gonna make it home in one piece.

This may not apply in your husband’s case, but it’s worth having the conversation. The two meds Goldstein prescribes for men ...

FROM NORTH AMERICA SYNDICATE, 300 W 57th STREET, 15th FLOOR, NEW YORK, NY 10019 ...

March 11 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has introduced a unified platform ‌designed to streamline the analysis of reports on drug side effects. Sign up here.

The Food and Drug Administration issued a warning letter to Novo Nordisk — the maker of Ozempic and Wegovy — for failing to report potential side effects in patients who took its blockbuster ...

A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their labels. Memory problems, depression, sleep issues, weight gain, and many ...

It’s worth the weight — loss, that is. Despite their blockbuster popularity, GLP-1 medications come with a handful of side effects, mainly along the lines of gastrointestinal issues like nausea and ...

Patients worried about potential side effects of statins can rest easy, according to a new large-scale study: The vast majority of adverse effects listed on statin medications simply never occur. The ...

The long list of side effects marked on the packaging of statins can be a turn-off for those who might benefit from the cholesterol-lowering drugs. But a new study found only a few of those side ...

New research suggests that it’s rare to experience most of the listed side effects for this common type of cholesterol-lowering medication. Misconceptions that statins come with a high risk of side ...

Benefits of statins greatly outweigh risks, study leader says Wrongly attributed side effects may discourage use by patients and doctors Regulators should change statin labeling, researchers say Feb 5 ...

The long list of side effects associated with statins is vastly overstated, according to the most rigorous assessment of the evidence to date. This is prompting calls for the drugs’ packaging to be ...